Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers (Non-alcoholic Steatohepatitis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Early research (Phase 1)Study completedNCT04193436
What this trial is testing

COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT

Who this might be right for
Hepatic ImpairmentHealthy Participants
Pfizer 23
Early research (Phase 1)Study completedNCT04422496
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
Sunshine Lake Pharma Co., Ltd. 73
Early research (Phase 1)Study completedNCT04561245
What this trial is testing

ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability

Who this might be right for
ObesityNonalcoholic Steatohepatitis
Altimmune, Inc. 100
Early research (Phase 1)Ended earlyNCT05668936
What this trial is testing

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 31
Early research (Phase 1)Study completedNCT03445208
What this trial is testing

Experimental Medication BMS-986036 Given to Healthy Participants

Who this might be right for
Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease+1 more
Bristol-Myers Squibb 30
Early research (Phase 1)Study completedNCT05733455
What this trial is testing

Effect of Alpelisib in Healthy Volunteers

Who this might be right for
Insulin ResistanceHyperinsulinemiaDyslipidemias
Columbia University 23
Not applicableStudy completedNCT02482558
What this trial is testing

Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects

Who this might be right for
Healthy
Unilever R&D 8
Early research (Phase 1)Study completedNCT06705998
What this trial is testing

To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects

Who this might be right for
NASH
BAR Pharmaceuticals s.r.l. 43
Early research (Phase 1)Study completedNCT04559126
What this trial is testing

EDP-297 in Healthy Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis
Enanta Pharmaceuticals, Inc 82
Early research (Phase 1)Study completedNCT00862433
What this trial is testing

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

Who this might be right for
DiabetesFatty LiverObesity+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Early research (Phase 1)Study completedNCT05848440
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 48
Early research (Phase 1)Study completedNCT05983328
What this trial is testing

Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers

Who this might be right for
Nonalcoholic Steatohepatitis
Sinew Pharma Inc. 14
Early research (Phase 1)Study completedNCT04845646
What this trial is testing

DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.

Who this might be right for
HealthyNAFLD
Gannex Pharma Co., Ltd. 24
Early research (Phase 1)Study completedNCT03809052
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Who this might be right for
Safety and Tolerability
Galecto Biotech AB 78
Early research (Phase 1)Study completedNCT05712265
What this trial is testing

Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Who this might be right for
Antipsychotic Induced Weight GainNon-alcoholic Steatohepatitis (NASH)
Corcept Therapeutics 26
Early research (Phase 1)UnknownNCT04481594
What this trial is testing

Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Hepanova Inc. 72
Early research (Phase 1)Study completedNCT06093542
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants.

Who this might be right for
Heathy Participants
AstraZeneca 12
Early research (Phase 1)Study completedNCT04972396
What this trial is testing

Pemvidutide (ALT-801) DDI Study in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Altimmune, Inc. 40
Early research (Phase 1)Study completedNCT05294458
What this trial is testing

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Who this might be right for
Non-alcoholic SteatohepatitisType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
AstraZeneca 10
Next Page